NOVEL SCREENING METHOD

Details for Australian Patent Application No. 2003211952 (hide)

Owner TAKEDA CHEMICAL INDUSTRIES, LTD.

Inventors ITO, Yasuaki; KOBAYASHI, Makoto; TANAKA, Hideyuki; OKUBO, Shoichi; FUJII, Ryo; KIZAWA, Hideki; KAWAMATA, Yuji; OGI, Kazuhiro; HARADA, Masataka; FUKUSUMI, Shoji; HINUMA, Shuji; HOSOYA, Masaki TANG, Jason, Tin-Shing see TANG, ShunYau (21) 2003203058

Pub. Number AU-A-2003211952

PCT Number PCT/JP03/01483

PCT Pub. Number WO2003/068959

Priority 2002-37131 14.02.02 JP; 2002-204163 12.07.02 JP; 2002-328696 12.11.02 JP; 2003-14032 22.01.03 JP

Filing date 13 February 2003

Wipo publication date 4 September 2003

International Classifications

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 031/711 - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 038/00 Medicinal preparations containing peptides

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 003/04 Drugs for disorders of the metabolism

A61P 003/06 Drugs for disorders of the metabolism

A61P 003/08 Drugs for disorders of the metabolism

A61P 003/10 Drugs for disorders of the metabolism

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 009/12 Drugs for disorders of the cardiovascular system

A61P 013/12 Drugs for disorders of the urinary system

A61P 025/00 Drugs for disorders of the nervous system

A61P 035/00 Antineoplastic agents

C07K 014/705 Peptides having more than 20 amino acids

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 2002-37131 14.02.02 JP; 2002-204163 12.07.02 JP; 2002-328696 12.11.02 JP; 2003-14032 22.01.03 JP

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2003211952

28 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003211953-NUCLEOSIDE ANALOGUES AND OLIGONUCLEOTIDE DERIVATIVE COMPRISING NUCLEOTIDE ANALOGUE THEREOF

2003211951-N-CARBAMOYL NITROGEN-CONTAINING FUSED RING COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT